Light People: Prof. Henry Snaith's (FRS) perovskite optoelectronics journey.

Light Sci Appl

Executive Management College of CHN ENERGY, No.7 Binhe Avenue, North District of Future Science City, Changping District, Beijing, 102211, China.

Published: January 2025

In 2012, Prof. Henry Snaith demonstrated the first solid-state perovskite solar cell (PSC) with an efficiency of 10.9%, igniting a surge of interest and research into perovskite materials for their potential to revolutionize the photovoltaic (PV) industry. Over the past two decades, perovskite optoelectronics have made remarkable progress, with significant improvements in efficiency, stability, and commercial viability, which has transformed these materials from a scientific curiosity into a leading platform for a wide range of applications, particularly in PVs and light-emitting diodes (LEDs). Prof. Henry Snaith's election as a Fellow of the Royal Society (FRS) credits to his groundbreaking discovery of the use of perovskites in efficient solar cells. In addition to his academic role, Henry co-founded and served as the Chief Scientific Officer (CSO) of two spin-off companies, Oxford PV Ltd. and Helio Display Materials Ltd., which focus on commercializing metal halide perovskite PVs and light-emitting applications, respectively. His team has led the global R&D community in advancing the fundamental understanding and practical use of perovskites since 2012. On 5th September 2024, Oxford PV announced the world's first commercial sale of next-generation perovskite tandem solar panels, which generate up to 20% more energy than a standard silicon panel. In an insightful conversation with Light: Science & Applications, Prof. Henry Snaith, a pioneer of metal halide perovskite optoelectronics, shared his story on how scientific curiosity, close observation to unexpected results, and serendipity led to the discovery of perovskite as a solid light absorber, as well as the key findings and breakthroughs to achieve the remarkable efficiency of PSCs. He highlighted the significant contribution of his team to the progress of PSC technology from its initial discovery to its current exciting commercialization status; this includes the development of tandem solar cells and the exploration of p-i-n configurations for better stability. Moreover, he expressed his views on the future of perovskite LEDs and environmental and safety concerns related to perovskite optoelectronics technology. The interviews further explored Henry's journey from an undergraduate physics student to a renowned scientist. His career success is undoubtedly driven by his ambition for immediate real-world impact and his relentless pursuit of more efficient, low-cost, and sustainable energy solutions to address global environmental challenges. When asked about the potential for a Nobel Prize, Henry acknowledged that PSC technology could be worthy of such recognition, given its scientific advancements and significant contributions to addressing the global challenge of climate change. Looking ahead, Henry has expressed an interest in contributing to public policy, particularly in the areas of renewable energy and education reform, with an emphasis on the creation of an inclusive education system that better supports neurodiversity.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41377-024-01668-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688497PMC

Publication Analysis

Top Keywords

prof henry
16
perovskite optoelectronics
16
perovskite
10
henry snaith's
8
henry snaith
8
scientific curiosity
8
pvs light-emitting
8
solar cells
8
metal halide
8
halide perovskite
8

Similar Publications

Light People: Prof. Henry Snaith's (FRS) perovskite optoelectronics journey.

Light Sci Appl

January 2025

Executive Management College of CHN ENERGY, No.7 Binhe Avenue, North District of Future Science City, Changping District, Beijing, 102211, China.

In 2012, Prof. Henry Snaith demonstrated the first solid-state perovskite solar cell (PSC) with an efficiency of 10.9%, igniting a surge of interest and research into perovskite materials for their potential to revolutionize the photovoltaic (PV) industry.

View Article and Find Full Text PDF
Article Synopsis
  • Traditional clinical guidelines often mismatch the strength of recommendations with the quality of evidence, prompting the need for improvement in the field of urinary tract infections (UTIs).
  • The objective was to create a comprehensive guideline that aligns evidence and recommendations better, utilizing a systematic review involving 54 experts across 12 countries who analyzed 914 articles on various aspects of UTIs.
  • Only 6 out of 37 questions could be clearly recommended based on strong evidence, while the rest resulted in clinical reviews outlining the risks and benefits of existing approaches.
View Article and Find Full Text PDF

Background: Tackling poor mental health in university students has been identified as a priority in higher education. However, there are few evidence-based prevention initiatives designed for students. Repetitive Negative Thought (RNT, e.

View Article and Find Full Text PDF

Advancing the chemotherapy of tuberculous meningitis: a consensus view.

Lancet Infect Dis

January 2025

Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa; The Francis Crick Institute, London, UK; Department of Infectious Diseases, Imperial College London, London, UK. Electronic address:

Article Synopsis
  • Tuberculous meningitis is a serious disease that can cause death or long-term problems for about half of the people it affects.
  • Current treatment methods are based on how we treat lung tuberculosis, but they don't work as well for the brain.
  • Researchers are calling for new global trials with better drugs to improve treatment and help patients with this dangerous infection.
View Article and Find Full Text PDF

Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study.

Clin Microbiol Infect

December 2024

OUTCOMEREA Research Group, Drancy, France; Institut National de la Santé et de la Recherche Medicale, Infection Antimicrobial Modelisation Evolution, U1137, Team Decision Science in Infectious Diseases, Paris, France; Assistance Publique Hôpitaux de Paris, Bichat hospital, Medical and infectious diseases ICU, F75018, Paris France. Electronic address:

Article Synopsis
  • Hospital-acquired bloodstream infections (HA-BSI) in ICU patients can be life-threatening, and this study aimed to see how early adequate antibiotic treatment affects 28-day mortality rates for patients who survive at least one day after infection onset.
  • Using data from a multicenter study with 2,418 patients, researchers found that those who received adequate treatment within 24 hours had a lower 28-day mortality rate (32.8%) compared to those who were inadequately treated (40%).
  • The study concluded that inadequate antibiotic therapy within 24 hours contributes significantly to 28-day mortality, indicating that quicker treatment could greatly improve patient outcomes in cases of HA-BSI.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!